Division of Medical Virology, Department of Pathology, Faculty of Health Sciences, University of Cape Town, Cape Town, South Africa.
Biopharming Research Unit, Department of Molecular and Cell Biology, Faculty of Science, University of Cape Town, Cape Town, South Africa.
Nanotechnology. 2022 Sep 12;33(48). doi: 10.1088/1361-6528/ac842c.
Two-component self-assembling virus-like particles (VLPs) are promising scaffolds for achieving high-density display of HIV-1 envelope (gp140) trimers, which can improve the induction of neutralising antibodies (NAbs). In this study gp140 was displayed on the surface of VLPs formed by the AP205 phage coat protein. The CAP256 SU gp140 antigen was selected as the patient who this virus was isolated from developed broadly neutralising antibodies (bNAbs) shortly after superinfection with this virus. The CAP256 SU envelope is also sensitive to several bNAbs and has shown enhanced reactivity for certain bNAb precursors. A fusion protein comprising the HIV-1 CAP256 SU gp140 and the SpyTag (ST) (gp140-ST) was produced in HEK293 cells, and trimers were purified to homogeneity using gel filtration. SpyCatcher (SC)-AP205 VLPs were produced inand purified by ultracentrifugation. The gp140-ST trimers and the SC-AP205 VLPs were mixed in varying molar ratios to generate VLPs displaying the glycoprotein (AP205-gp140-ST particles). Dynamic light scattering, negative stain electron microscopy and 2D classification indicated that gp140-ST was successfully bound to the VLPs, although not all potential binding sites were occupied. The immunogenicity of the coupled VLPs was evaluated in a pilot study in rabbits. One group was injected four times with coupled VLPs, and the second group was primed with DNA vaccines expressing Env and a mosaic Gag, followed by modified vaccinia Ankara expressing the same antigens. The animals were then boosted twice with coupled VLPs. Encouragingly, gp140-ST displayed on SC-AP205 VLPs was an effective boost to heterologously primed rabbits, leading to induction of autologous Tier 2 neutralising antibodies in 2/5 rabbits. However, four inoculations of coupled VLPs alone failed to elicit any Tier 2 antibodies. These results demonstrate that the native-like structure of HIV-1 envelope trimers and selection of a geometrically-suitable nanoparticle scaffold to achieve a high-density display of the trimers are important considerations that could improve the effect of nanoparticle-displayed gp140.
两亲性自组装病毒样颗粒 (VLPs) 是实现 HIV-1 包膜 (gp140) 三聚体高密度展示的有前途的支架,可提高中和抗体 (NAb) 的诱导。在这项研究中,gp140 被展示在由 AP205 噬菌体衣壳蛋白形成的 VLPs 表面。选择 CAP256 SU gp140 抗原作为从该病毒中分离出来的患者的抗原,该患者在被该病毒超感染后不久就产生了广泛中和抗体 (bNAb)。CAP256 SU 包膜也对几种 bNAb 敏感,并显示出对某些 bNAb 前体的增强反应性。包含 HIV-1 CAP256 SU gp140 和 SpyTag (ST) (gp140-ST) 的融合蛋白在 HEK293 细胞中产生,并使用凝胶过滤纯化至均一性。SpyCatcher (SC)-AP205 VLPs 在和中产生,并通过超速离心纯化。将 gp140-ST 三聚体和 SC-AP205 VLPs 以不同的摩尔比混合以生成展示糖蛋白的 VLPs (AP205-gp140-ST 颗粒)。动态光散射、负染色电子显微镜和 2D 分类表明,gp140-ST 成功结合到 VLPs 上,尽管并非所有潜在的结合位点都被占据。在兔的初步研究中评估了偶联 VLPs 的免疫原性。一组兔接受了四次偶联 VLPs 注射,第二组用表达 Env 和马赛克 Gag 的 DNA 疫苗进行了 priming,然后用表达相同抗原的改良安卡拉牛痘病毒进行了 priming。然后,这些动物用偶联 VLPs 进行了两次加强。令人鼓舞的是,在异源 primed 的兔子中,展示在 SC-AP205 VLPs 上的 gp140-ST 是一种有效的加强,导致 2/5 只兔子诱导出自体 Tier 2 中和抗体。然而,单独接种四次偶联 VLPs 未能引起任何 Tier 2 抗体。这些结果表明,HIV-1 包膜三聚体的天然样结构和选择几何上合适的纳米颗粒支架以实现三聚体的高密度展示是重要的考虑因素,可提高纳米颗粒展示的 gp140 的效果。